In the course of examining the structure 
Introduction
Three classes of receptors for the Fc regions of IgG immunoglobulins are expressed on the surfaces of human leukocytes (1, 2) . One of these, Fc receptor III (FcyRIII),' is a glycoprotein that is expressed in a heterogeneous manner on the surfaces of human neutrophils, natural killer (NK) cells, and macrophages. FcyRIII on neutrophils and FcyRIII on NK cells differ with respect to their apparent molecular masses (3) , and are products of distinct, but highly homologous, genes that are expressed in a cell-specific fashion (4) . Two alleles (NA1 and (4) (5) (6) . Both forms of neutrophil FcyRIII are anchored to the cell membrane via a glycosyl linkage to phosphatidylinositol (PI) (4, 7-1 1), while the NK cell receptor is a transmembrane protein (4, (9) (10) (11) . Macrophage FcyRIII presumably is identical to NK cell FcyRIII (4) .
FcyRIII mediates binding ofIgG-coated particles to phagocytic cells in vitro (1, 2) , and probably facilitates clearance of circulating immune complexes by tissue macrophages in vivo (12) . Indeed, previous studies have shown that FcyRIII mediates the removal of IgG-coated erythrocytes (RBCs) from the circulation of chimpanzees (12) as well as the removal of IgGcoated platelets from the circulation of humans (13) .
In this report, we describe a patient with systemic lupus erythematosus (SLE) whose [23] ) of a cDNA which encodes the NAI form of neutrophil Fc-yRIII (6) .
To examine FcyRIII gene-specific sequences in more detail, fragments of genomic DNA were amplified using the polymerase chain reaction (PCR) (24) . Synthetic oligonucleotide primers were complementary to bases (611-625 and 805-825 of a corresponding cDNA) which flank a region of genomic DNA that contains two gene-specific restriction sites (4) (Fig. 1) . The PCR was performed as described previously (24) , using reagents from Perkin-Elmer (Norwalk, CT), 20 ug genomic DNA, 0.1 mol each of the oligonucleotide primers, 20 MCi [132PJdATP, and 2.5 U Taq DNA polymerase. Aliquots of reaction mixtures subjected to 40 cycles of denaturation (94°C for 2 min), annealing (55°C for 2 min), and extension (72°C for 3 min) were examined by PAGE and autoradiography before and after digestion with either Taq I or Dra I (New England Biolabs).
Results
Patient. E.W. is a 34-yr-old black woman with a 9-yr history of SLE. Clinically, she has had a cerebrovascular accident, glomerulonephritis, Raynaud's phenomenon, severe cutaneous vasculitis with lower extremity ulcers, and recurrent pleuritis. Laboratory abnormalities at the time she was initially studied included a Coomb's-positive anemia, antinuclear antibodies, and anti-DNA antibodies. Medications included chlorambucil (4 mg daily) and prednisone (15 mg daily). Her family history is remarkable only for a sister with an undefined inflammatory arthritis. Eight other siblings are alive and well.
Neutrophils from patient E. W. do not express normal FcyRIII. Shown in Fig. 2 are the results of a representative experiment in which neutrophils from patient E.W. and neutrophils from a healthy control donor were examined for their reactivity with the anti-FcyRIII MAbs, 3G8 and Leu 1 lb, and with the isotype-specific, control myeloma proteins MOPC 21 and TEPC 183. Reactivity of the patient's neutrophils did not exceed the background reactivity observed with the control myeloma proteins. In contrast, cells from the control donor reacted strongly with MAbs 3G8 and Leu 1 lb. Similarly, reactivity of the patient's neutrophils with antibodies that recognize the NA I and NA2 allotypic forms of neutrophil Fc'yRIII did not reproducibly exceed that observed when cells were incubated with normal human serum. Cells from the control donor, however, reacted strongly with the anti-NA 1 and anti-NA2 alloantisera. It should be noted that neutrophils from all of the control donors examined, as well as neutrophils from eight other patients with SLE, reacted as expected with the anti-FcyRIII MAbs, 3G8 and Leu 1 lb, and with antisera directed against NA1 and/or NA2. In experiments not shown, neutrophils from patient E.W. were comparable to neutrophils from a healthy control donor with respect to their reactivity with MAbs to FcyRII, complement receptor 1, and complement receptor 3.
Consistent with our observations using flow cytometry, we were unable to immunoprecipitate FcyRIII from lysates of surface-labeled neutrophils obtained from patient E.W. As described previously (5), FcyRIII on neutrophils from a control appeared as a broad band from 50-70 kD after immunoprecipitation with MAb 3G8 and SDS-PAGE. MAb 3G8, however, did not precipitate any labeled proteins from the patient's neutrophils (not shown).
Neutrophils Fig. 1 ).
To confirm this, we examined the patient's genomic DNA further for gene-specific sequences.
As expected, using the PCR and synthetic oligonucleotide primers complementary to bases 61 1-625 and bases 805-825 of the cDNA that encodes neutrophil FcyRIII, we were able to amplify identical 215-bp fragments from genomic DNA of patient. E.W. and the control (Fig. 6) . However, whereas all of the fragments amplified from the patient's genomic DNA were susceptible to digestion with Taq I and Dra I, only a portion of those amplified from control genomic DNA were cleaved with these enzymes. These results also indicate that the NK cell FcyRIII gene is normal in patient E.W., but that the neutrophil FcyRIII gene is not (see Fig. 1 ).
Discussion
In the course of examining the structure and function of Fc receptors on peripheral blood cells of patients with SLE, we. identified a patient whose neutrophils did not react with either monoclonal or polyclonal antibodies to FcyRIII (Fig. 2) . Neutrophils from the patient were comparable to neutrophils from healthy controls, however, with respect'to their expression of Fc7RII, complement receptor 1, complement receptor 3, and DAF (Fig. 3) (34) (35) (36) .
Abnormal expression of Fc receptors on peripheral blood leukocytes has been reported previously. For example, as indicated above, neutrophils from, patients with paroxysmal nocturnal hemoglobinuria express reduced amounts of FcyRIII on their surfaces, along with reduced amounts of other proteins that are anchored to PI (7). In addition, Ceuppens et 
